Papers 21–30 of
44
by Melvin E Andersen
- S Haider, MB Black, BB Parks, B Foley, BA Wetmore, ME Andersen, RA Clewell, K Mansouri, and PD McMullen. A Qualitative Modeling Approach for Whole Genome Prediction Using High-Throughput Toxicogenomics Data and Pathway-Based Validation. Front Pharmacol 9 : 1072 (Oct 2, 2018). [abstract] [pubmed]
- Y Hou, Z Liu, Z Zuo, T Gao, J Fu, H Wang, Y Xu, D Liu, M Yamamoto, B Zhu, Y Zhang, ME Andersen, Q Zhang, and J Pi. Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice. Biochem Biophys Res Commun 503 (1) : 264-270 (Sep 3, 2018). [abstract] [pubmed]
- RK Leak, EJ Calabrese, WJ Kozumbo, JM Gidday, TE Johnson, JR Mitchell, CK Ozaki, R Wetzker, A Bast, RG Belz, HE Bøtker, S Koch, MP Mattson, RP Simon, RL Jirtle, and ME Andersen. Enhancing and Extending Biological Performance and Resilience. Dose Response 16 (3) : 1559325818784501 (Aug 15, 2018). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, DE Dodd, JS Bus, SS Sarang, MI Banton, R Waites, DB Layko, and PD McMullen. Strain-related differences in mouse lung gene expression over a two-year period of inhalation exposure to styrene: Relevance to human risk assessment. Regul Toxicol Pharmacol 96 : 153-166 (Jul 17, 2018). [abstract] [pubmed]
- G Cruzan, JS Bus, ME Andersen, GP Carlson, MI Banton, SS Sarang, and R Waites. Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern. Regul Toxicol Pharmacol 95 : 17-28 (Jun 26, 2018). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, D Dodd, JS Bus, SS Sarang, MI Banton, R Waites, and PD McMullen. Assessing molecular initiating events (MIEs), key events (KEs) and modulating factors (MFs) for styrene responses in mouse lungs using whole genome gene expression profiling following 1-day and multi-week exposures. Toxicol Appl Pharmacol 335 : 28-40 (Nov 15, 2017). [abstract] [pubmed]
- JL Campbell, ME Andersen, C Van Landingham, R Gentry, E Jensen, JY Domoradzki, and HJ Clewell. Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment. Toxicol Lett 279 Suppl 1 : 125-135 (Oct 20, 2017). [abstract] [pubmed]
- G Cruzan, JS Bus, MI Banton, SS Sarang, R Waites, DB Layko, J Raymond, D Dodd, and ME Andersen. Editor's Highlight: Complete Attenuation of Mouse Lung Cell Proliferation and Tumorigenicity in CYP2F2 Knockout and CYP2F1 Humanized Mice Exposed to Inhaled Styrene for up to 2 Years Supports a Lack of Human Relevance. Toxicol Sci 159 (2) : 413-421 (Oct 1, 2017). [abstract] [pubmed]
- ME Andersen, MB Black, JL Campbell, SN Pendse, HJ Clewell, LH Pottenger, JS Bus, DE Dodd, DC Kemp, and PD McMullen. Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver. Toxicol Appl Pharmacol 332 : 149-158 (Oct 1, 2017). [abstract] [pubmed]
- MM Miller, PD McMullen, ME Andersen, and RA Clewell. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts. Crit Rev Toxicol 47 (7) : 564-580 (Aug 4, 2017). [abstract] [pubmed]